Home
Onyx Pharmaceuticals

Onyx Pharmaceuticals Market Share Analysis for June 2026

onyx pharmaceuticals (nasdaq: onxx) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.

Health > Biotechnology and Pharmaceuticals

Domainonyx-pharm.com

Year Founded1991

Employees501 - 1000

Annual Revenue$10M - $15M

Onyx Pharmaceuticals

Onyx Pharmaceuticals (including company regionals)

onyx-pharm.com

See more website traffic and engagement information

Onyx Pharmaceuticals Revenue up to June 2026 is 10M - 15M

revenue generated by Onyx Pharmaceuticals top domains

Onyx Pharmaceuticals top domains revenue over 3 years

Revenue for Onyx Pharmaceuticals top domains

onyx-pharm.com10M - 15M

See more with Sales Intelligence

Total visits to Onyx Pharmaceuticals's top domains

Understand Onyx Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Onyx Pharmaceuticals's top domains

Analyze Onyx Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Onyx Pharmaceuticals's top domains

See how Onyx Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Onyx Pharmaceuticals top competitors by domain

Top similar sites in June 2026, ranked by their affinity

exelixis.comCompany NameExelixisEmployees1001 - 5000HQUnited States, California, AlamedaAnnual revenue> $1BTotal visits148.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Onyx Pharmaceuticals

looks like we dont have enough data

No Data to Display

News & Signals from Onyx Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTrifan leaves Onyx Pharm.Dr. Trifan joins Apexigen from Onyx Pharmaceuticals with extensive expertise in oncology research and product development.

NewsAmgen Foundation, Inc. acquired Onyx Pharm for $10.4B on Jan 1st '13.Amgen struck a deal to buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion, as it moves to restock its product pipeline in response to declining sales of its flagship anemia drugs.